Organyc feminine care brand makes U.S. debut
Italian personal care manufacturer Corman has introduced the Organyc brand and new private-label feminine care lines in the United States.
Supplier News
GSK puts Advantage Brands plan in action
GlaxoSmithKline Consumer Healthcare (GSK) has established several key sales, marketing and merchandising objectives for its retail partners in 2010 to capitalize on its Advantage Brands strategy, according to Mike McCormick, director of the initiative.
Get ready for Valentine’s Day
If, as someone once said, “timing is everything,” the timing of Valentine’s Day this year does not favor chain drug retailers.
Questions about consumers linger as ’10 begins
Americans still seem relatively unconvinced that there will be dramatic economic improvement this year, and that attitude will continue to impact shoppers’ purchasing habits, according to consumer market researchers.
PharmaSmart, AstraZeneca ally on Rx hypertension program
PharmaSmart International Inc. has teamed up with AstraZeneca Canada to deliver tools and programs to pharmacists, doctors and patients for the improved management of hypertension.
P&G extends Vicks DayQuil line
Procter & Gamble Co. has introduced a cough remedy that’s aimed at helping to eliminate one of a cough’s most embarrassing aspects: clearing mucus from the throat. P&G’s new Vicks DayQuil Mucus Control and DayQuil Mucus Control DM are designed to loosen and thin mucus.
AstraZeneca to purchase specialty drug maker Novexel
AstraZeneca plans to acquire specialty pharmaceutical manufacturer Novexel in a deal worth up to $505 million.
Novartis to get rights to heart failure drug via acquisition
Novartis stands to gain exclusive global rights to heart failure drug relaxin through a deal to acquire U.S. biopharmaceutical firm Corthera Inc. The Swiss pharmaceutical giant said Wednesday that, under the agreement, it plans to acquire all of the outstanding shares of San Mateo, Calif.
Sanofi-aventis in deal to acquire Chattem
Sanofi-aventis has inked an agreement to buy Chattem Inc. for $1.9 billion, a deal that the drug makers say would create the world’s fifth-largest consumer health care company.
Energizer Holdings board member to step down
Energizer Holdings Inc. director Joe Micheletto has resigned from the household and personal care manufacturer’s board. The company said Thursday that Micheletto is retiring and plans to step down from the board effective January 2.
Merck to buy Avecia Biologics
Merck & Co. has agreed to acquire Avecia Biologics, a contract manufacturing organization specializing in microbial-derived biologics. Financial terms of the deal weren’t disclosed. Under the agreement, made with Avecia Investments Ltd.
Unilever appoints Bristol-Myers exec as CFO
Jean-Marc Huet, currently chief financial officer at Bristol-Myers Squibb Co., is joining Unilever as CFO. Unilever said Wednesday that the 40-year-old Huet will take over the company’s CFO post starting January 1.
Bristol-Myers Squibb names acting CFO
Bristol-Myers Squibb Co. has appointed Charles Bancroft as acting chief financial officer, effective January 1. The pharmaceutical company said Monday that Jean-Marc Huet, executive vice president and CFO, will leave the firm at the end of this year.
Alberto Culver to acquire Simple Health & Beauty
Alberto Culver Co. plans to buy Simple Health & Beauty Ltd., a United Kingdom-based skin care supplier, from private equity fund Duke Street for 240 million pounds ($390 million). The deal is expected to close by the end of this year, Alberto Culver said Monday. The company noted that Simple is
Study: Organic products not drawing more consumers
Although many traditional retailers are expanding their offerings of organic food and beauty products, there has actually been no growth in the number of U.S. consumers that purchase these products, according to a study by market research firm TABS Group.
P&G to buy Sara Lee air care business
Procter & Gamble Co. has entered an agreement to acquire Sara Lee Corp.’s Ambi Pur air care business for 320 million euro ($470 million). P&G said Friday that, under the terms of the deal, it will purchase Ambi Pur, a leading global air care brand with presence in 80 countries, as well as several